← Back to Search

Communication Strategies for Vaccine Uptake in Healthy Subjects

N/A

Recruiting

Led By Dan Ariely, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1, day 30, day 60, day 90

Awards & highlights

Study Summary

This trial looks at how doctors and medical providers decide if and when to recommend vaccinations.

Who is the study for?

This trial is for healthcare professionals like doctors, nurses, and medical students who are authorized to recommend vaccines. It's not open to those under the supervision of the principal investigator (PI) even if they meet other requirements.Check my eligibility

What is being tested?

The study looks at how physicians and advanced practice providers perceive vaccine recommendations and their related behaviors. It tests different ways of making these recommendations, including using social norms, trust-building language, and a control group with no intervention.See study design

What are the potential side effects?

Since this trial focuses on communication strategies rather than medical treatments or drugs, there are no physical side effects involved. However, it may influence professional practices regarding vaccine recommendation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1, day 30, day 60, day 90

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1, day 30, day 60, day 90

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 30, day 60, day 90 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in proportion of patients that receive a vaccine recommendation

Change in self-reported assessment of patient recommendation acceptance

Change in self-reported patient trust

+3 more

Secondary outcome measures

Change in belief about patient autonomy

Change in proportion of patients that accept a recommendation

Trial Design

4Treatment groups

Experimental Treatment

Group I: Quantity (present) x Quality (present)Experimental Treatment2 Interventions

Participants will receive a social norm-based message (for quantity) and will learn the AIMS method, a trust-building method using presumptive language (for quality).

Group II: Quantity (present) x Quality (absent)Experimental Treatment1 Intervention

Participants will receive a social norm-based message (for quantity).

Group III: Quantity (absent) x Quality (present)Experimental Treatment1 Intervention

Participants will learn the AIMS method, a trust-building method using presumptive language (for quality).

Group IV: Quantity (absent) x Quality (absent)Experimental Treatment1 Intervention

Control: Participants in this condition will receive general information about vaccines, including vaccine principles, uptake barriers, and guidelines. This information will come directly from the CDC's Advisory Committee on Immunization Practices (ACIP) website.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,358 Previous Clinical Trials

3,419,729 Total Patients Enrolled

Dan Ariely, PhDPrincipal InvestigatorDuke University

1 Previous Clinical Trials

38 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum number of participants that this clinical trial can accommodate?

"Affirmative. Clinicaltrials.gov data attests that this investigation began on September 21st 2023 and is still actively recruiting participants as of October 20th 2023. There are 340 vacancies for patients at one medical facility."

Answered by AI

Are investigators in this trial actively recruiting participants?

"Affirmative. The clinical trial registry holds information that indicates this research is actively seeking participants, with 340 patients needed from 1 centre. This study was first published on September 21st 2023 and the most recent edition occurred October 20th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Physician Vaccine Recommendation Using Social Norms, Trust, and Presumptive Language

2023. "Improving Physician Vaccine Recommendation Using Social Norms, Trust, and Presumptive Language". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05957393.